Get Your Patients Started on ZEPOSIA
Preinitiation Assessment Assistancea
Provided at the homes of eligible patients:
ZEPOSIA Starter Kit
Eligible patients enrolled in ZEPOSIA 360 SupportTM, who have been cleared to begin treatment, and who have not received a sample from their provider, will be provided a
starter kit that includes a 7-day starter pack and a 30-day supply of ZEPOSIA.
Access Assistance
Help with Benefits Investigation, Prior Authorization (PA), and Appeals
ZEPOSIA Bridge Programb
Commercially insured patients may be eligible to receive up to 24 months of ZEPOSIA through the Bridge Program if there is a delay in determining coverage.
For assistance, call 1-833-ZEPOSIA (833-937-6742)
Co-pay Assistance Programc
ZEPOSIA 360 SupportTM may be able to identify possible financial assistance options for eligible, commercially insured patients.
For financial assistance and support, call 1-833-ZEPOSIA (833-937-6742)
Fax: 833-727-7701
Monday thru Friday
8 AM until 8 PM ET
Or visit us online at: ZEPOSIAportal.com
Dedicated GI NURSE NAVIGATORS* are available to support patients
on every step of their treatment journey
*Nurse Navigators do not provide medical advice.
ECG=electrocardiogram; VZV=varicella-zoster virus.
For additional access resources, click here.
Dr Wolf speaks with a long time UC patient, Tim. Together they discuss his diagnosis and treatment journey, as well as the challenges that Tim has faced
Dr Wolf was compensated for his time. Tim is an actual patient. He was compensated for his time.
Individual results may vary. See clinical trial results at ZEPOSIAhcp.com/UCresults
Resources to help you learn more about ZEPOSIA for the treatment of ulcerative colitis and to help get your patients started.
ZEPOSIA Start Form Instructions & Support
A step-by-step guide that outlines how to enroll patients in the ZEPOSIA 360 Support™ Program and get them started on treatment
Dosing, Initiation, and Patient Support Guide
Provides information on how to initiate treatment with ZEPOSIA, and education on the patient support offered to assist with the process
BMS eSign
Available for your patients who forget to sign the ZEPOSIA Start Form. BMS eSign enables your patients to electronically sign
Baseline Testing Clearance Form
Used by ZEPOSIA 360 SupportTM clinical partners to verify that a patient’s baseline tests have been reviewed by their prescriber and that they are able to start therapy
Access and Reimbursement Guide
Provides information on the process for accessing ZEPOSIA from initiation to delivery, coverage authorizations and appeals, and patient support offered by the ZEPOSIA 360 SupportTM Program
ZEPOSIA 360 SupportTM Guide
Helps providers and office staff get appropriate patients the support they need
Specialty Pharmacy Resource
Provides a quick overview of the benefits of using specialty pharmacies (SPs) and a list of SPs ready to handle ZEPOSIA prescriptions
Patient Access Letters
Template letters (Formulary Exception, Medical Necessity, Appeals) to assist in getting appropriate patients access for ZEPOSIA
Patient Brochure
Provides your patients with an overview of clinical study results, safety, and support information for ZEPOSIA
Treatment Options Overview
A comprehensive guide to current select approved treatment options for patients with moderate-to-severe UC that includes all classes of treatment
Patient Getting Started Brochure
Provides a comprehensive guide to your patients about getting started on ZEPOSIA
ZEPOSIA UC Patient Profile – Bio-exposed
Meet Jorge. At first, he found relief with biologic treatment, but his symptoms are worsening. Learn more.
Tyramine and ZEPOSIA Food and Drug Interaction Information
A helpful list of foods and beverages that are high in tyramine (150 mg or more)—a compound that should be avoided if your patients are taking ZEPOSIA
ZEPOSIA UC Patient Profile – Bio-naïve
Meet Leah. She was initially able to manage her disease with diet and 5-ASAs, but that is no longer providing relief. Learn more.
Tyramine and ZEPOSIA Food and Drug Interaction Information
A helpful list of foods and beverages that are high in tyramine (150 mg or more)—a compound that should be avoided if your patients are taking ZEPOSIA
This website is best viewed
using the horizontal display on
your tablet device.
This website is best viewed
using the vertical display on
your mobile device.